共 50 条
- [34] Ruxolitinib reduces JAK2 p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE study Annals of Hematology, 2017, 96 : 1113 - 1120
- [35] Observation of a higher JAK2 V617F homozygous mutated clone in polycythemia vera compared to essential thrombocythemia Frontiers of Medicine in China, 2008, 2 (3): : 309 - 313
- [40] Hydroxyurea dose impacts hematologic parameters In polycythemia vera and essential thrombocythemia but does not appreciably affect JAK2-V617F allele burden HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (03):